Nucleic Acid Delivery for Vaccines and Next-Gen Therapeutics

Avanti Polar Lipids, part of Croda Pharma, develops innovative lipids of unparalleled purity to solve the stability and delivery issues associated with mRNA for use in vaccines and next-generation therapeutics. We develop and manufacture highly specialised lipids used in Lipid Nanoparticle (LNP) delivery technology to solve the stability and delivery issues associated with mRNA-based vaccines and therapeutics. We have a wide portfolio of phospholipids, cationic lipids, PEG lipids and sterols. Our formulations division develops custom lipid-based drug delivery systems for a range of pharmaceutical applications. Our expertise is also in development, scale-up and manufacturing of lipids under cGMP. We also provide contract manufacturing services for proprietary lipids. Please contact us via our exhibitor profile, or visit us at stand 80G90 to speak directly to our experts.